Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2014
04/30/2014CN103764164A Production of dense bodies (db) from hcmv-infected cells
04/30/2014CN103756669A Indole pH fluorescence probe, and preparation method and application thereof
04/30/2014CN103755695A Amide compounds with antitumor activity and application of amide compounds
04/30/2014CN103755686A Piperidyl substituted 5-hydroxytryptophane derivatives with anti-platelet aggregation activity
04/30/2014CN103755685A Purifying and refining method of esomeprazole sodium
04/30/2014CN103755684A Preparation method of baquiloprim
04/30/2014CN103755683A Treatment method of bilastine reaction mother liquor
04/30/2014CN103755682A Novel crystal form for desloratadine and preparation method thereof
04/30/2014CN103755681A 3-(2,2,3,3-tetrafluoropropoxy)-pyrazole amide compound and application thereof
04/30/2014CN103755647A C2-bit derivative of 4(3H)-quinazolinone and preparation method and application thereof
04/30/2014CN103755595A Hydroxamic acid derivative and application thereof
04/30/2014CN103755587A Derivatives of 4-polyfluoroalkyl-2,4-disubstituted pyrrole and preparation method thereof
04/30/2014CN103254170B Pyrazole ring-containing pesticide
04/30/2014CN103073535B Synthetic method of imidacloprid
04/30/2014CN102797150B Halamine antibacterial agent, its preparation method and application
04/30/2014CN102558157B Ethoxyl-triazole compound or amonoethyl-triazole compound and preparation method and application thereof
04/30/2014CN102548558B Novel aminopyridine derivatives having Aurora A selective inhibitory action
04/30/2014CN102112467B Pyrimidine derivative as kinase inhibitors
04/30/2014CN101896481B Pyrimidyl indoline compound
04/30/2014CN101743238B 3-(imidazolyl)-pyrazolo[3,4-b]pyridines
04/30/2014CN101735797B Red phosphorescent macromolecular iridium complex electroluminescent material and preparation method thereof
04/30/2014CN101668742B Bridged six-membered ring compounds
04/30/2014CN101633655B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
04/30/2014CN101484420B Indoles as 5-HT6 modulators
04/29/2014US8710261 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
04/29/2014US8710232 Imidazole derivatives used as TAFIa inhibitors
04/29/2014US8710229 Hepatitis C virus inhibitors
04/29/2014US8710223 Protein kinase C inhibitors and uses thereof
04/29/2014US8710174 Triazine ring-containing polymer and film-forming composition comprising same
04/29/2014US8710084 Tetrazolyl oxime derivative, salt thereof, and plant disease control agent
04/29/2014US8710082 Benzimidazole inhibition of biofilm formation
04/29/2014US8710081 5-lipoxygenase-activating protein (FLAP) inhibitors
04/29/2014US8710080 Prodrugs of [4 [4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1H-pyrrolo-pyridin-yl)-methanones and synthesis thereof
04/29/2014US8710078 Crystalline solvates of 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride
04/29/2014US8710076 2,5-disubstituted piperidine orexin receptor antagonists
04/29/2014US8710062 Piperazinedione compounds
04/29/2014US8710060 Piperazinyl methyl phenyl cyclohexane compound
04/29/2014US8710058 Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
04/29/2014US8710055 Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
04/29/2014US8710049 Diaminocyclohexane compounds and uses thereof
04/29/2014US8710043 TRPM8 antagonists and their use in treatments
04/29/2014US8709513 Liquid formulations of carboxamide arthropodicides
04/29/2014US8709129 Compounds useful as ligands of actinides, their synthesis and their uses
04/29/2014CA2753552C N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
04/29/2014CA2734877C [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
04/29/2014CA2681206C 8-(heteroarylmethoxy)quinoline compounds as bradykinin b2 receptor modulators
04/29/2014CA2661741C N-pyridylpiperidine compound, method for producing the same, and pest control agent
04/29/2014CA2655573C Therapeutic or prophylactic agent for multiple sclerosis
04/29/2014CA2637631C Pyrimidine compounds and uses thereof
04/29/2014CA2573976C Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
04/29/2014CA2570873C Pyrimidine urea derivatives as kinase inhibitors
04/24/2014WO2014062938A1 Rory modulators
04/24/2014WO2014062732A1 Substituted benzene compounds
04/24/2014WO2014062667A1 Phenyl linked quinolinyl modulators of ror-gamma-t
04/24/2014WO2014062658A1 Methylene linked quinolinyl modulators of ror-gamma-t
04/24/2014WO2014062655A1 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
04/24/2014WO2014061991A1 Novel organic electroluminescent compounds and organic electroluminescent device containing the same
04/24/2014WO2014061963A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same
04/24/2014WO2014061961A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same
04/24/2014WO2014061960A1 Compound for organic electroluminescent device, organic electroluminescent device and electronic device thereof using same
04/24/2014WO2014061882A1 Diaromatic amino acid substrate for cathepsin detection
04/24/2014WO2014060908A1 Improved process for preparation of revaprazan hydrochloride
04/24/2014WO2014060493A2 N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
04/24/2014WO2014060449A1 Multicomponent crystalline system comprising nilotinib and selected co-crystal formers
04/24/2014WO2014060386A1 Indol-amide compounds as beta-amyloid inhbitors
04/24/2014WO2014060375A2 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
04/24/2014WO2014060371A1 Inhibitors of syk
04/24/2014WO2014060341A1 Substituted carbamate compounds and their use as transient receptor potential (trp) channel antagonists
04/24/2014WO2014060328A1 6-aminoindole derivatives as trp channel antagonists
04/24/2014WO2014059518A1 Solid forms of nilotinib hydrochloride
04/24/2014WO2013162148A9 Compound for organic optoelectric device, organic light emitting device containing same, and display device containing said organic light emitting device
04/24/2014WO2012116246A3 Pesticidal compostions and processes related thereto
04/24/2014US20140114067 Benzimidazole derivatives as mitochondrial function modulators
04/24/2014US20140114064 P38 map kinase inhibitors
04/24/2014US20140113938 Pyrrole Inhibitors of S-Nitrosoglutathione Reductase
04/24/2014US20140113935 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same
04/24/2014US20140113934 Heterocyclic compounds for treating helminth infections
04/24/2014US20140113931 Substituted picolinamide kinase inhibitors
04/24/2014US20140113907 Pyridylaminoacetic acid compound
04/24/2014US20140113892 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
04/24/2014US20140113891 Compounds that inhibit human DNA ligases and methods of treating cancer
04/24/2014US20140113890 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
04/23/2014EP2722905A1 Light emitting element material and light emitting element
04/23/2014EP2722329A1 Indol-amide compounds as beta-amyloid inhbitors
04/23/2014EP2721025A1 New selective ccr2 antagonists
04/23/2014EP2721024A1 Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide solubilized using organic acids
04/23/2014EP2721023A1 Metalloenzyme inhibitor compounds
04/23/2014EP2721022A1 Metalloenzyme inhibitor compounds
04/23/2014EP2721021A1 Metalloenzyme inhibitor compounds
04/23/2014EP2721020A2 Metalloenzyme inhibitor compounds
04/23/2014EP2721019A1 Therapeutically active compositions and their methods of use
04/23/2014EP2721008A1 Hydroxy substituted isoquinolinone derivatives
04/23/2014CN103748099A Macrocyclic compounds as protein kinase inhibitors
04/23/2014CN103748093A Substituted imidazopyridinyl-aminopyridine compounds
04/23/2014CN103748088A Inhibitors of bruton's tyrosine kinase
04/23/2014CN103748087A Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
04/23/2014CN103748086A Pyridine-and pyrazine derivatives
04/23/2014CN103748079A Pyridazinone compounds and their use as DAAO inhibitors
04/23/2014CN103748073A Novel soft PDE4 inhibitors
04/23/2014CN103739595A Compounds and compositions as protein kinase inhibitors
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 1080